Skip to main content
. 2017 Jun 19;7:3821. doi: 10.1038/s41598-017-04186-7

Figure 2.

Figure 2

HCV infection results in IFN-λ4 expression and IFN-α unresponsiveness that is restored by DAA treatment. (A) PHHs were infected with JFH1 HCVcc at 2 MOI. Shortly after HCV infection, telaprevir (5 μM) plus sofosbuvir (5 μM) were added to HCV-infected cells. After 24 or 48 hours, the cells were harvested, and gene expression was analysed by real-time qPCR. (B) PHHs with the IFNL4 ΔG/ΔG genotype were infected with JFH1 HCVcc at 2 MOI. Six hours after HCV infection, the culture medium was changed to the medium containing telaprevir (5 μM) and sofosbuvir (5 μM). After 120 hours, the cells were treated with 100 IU/ml of IFN-α for 30 minutes (B) or 6 hours (C). The cells were harvested, and gene and protein expression were analysed by immunoblotting (B) or real-time qPCR (C). Data are presented as means ± S.E.M. ***P ≤ 0.001 (Student’s t-test). DAA: direct-acting antivirals. All the data are representative of two independent experiments. Full-length blots of PY-STAT1 (B) with multiple exposure times are included in the Supplementary Fig. 9B. The data are representative of three independent experiments.